Oscar Health, Inc. (OSCR) Falls More Steeply Than Broader Market: What Investors Need to Know

In the latest trading session, Oscar Health, Inc. (OSCR) closed at $13.00, marking a -2.99% move from the previous day. The stock's change was less than the S&P 500's daily loss of 1.52%. On the other hand, the Dow registered a loss of 1.56%, and the technology-centric Nasdaq decreased by 1.78%.

The company's shares have seen a decrease of 1.47% over the last month, surpassing the Finance sector's loss of 5.37% and the S&P 500's loss of 2.25%.

The upcoming earnings release of Oscar Health, Inc. will be of great interest to investors. On that day, Oscar Health, Inc. is projected to report earnings of $1.21 per share, which would represent year-over-year growth of 31.52%. Meanwhile, our latest consensus estimate is calling for revenue of $4.89 billion, up 60.62% from the prior-year quarter.

Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $0.2 per share and revenue of $18.91 billion. These totals would mark changes of +111.83% and +61.62%, respectively, from last year.

Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Oscar Health, Inc. These recent revisions tend to reflect the evolving nature of short-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the business outlook.

Empirical research indicates that these revisions in estimates have a direct correlation with impending stock price performance. To take advantage of this, we've established the Zacks Rank, an exclusive model that considers these estimated changes and delivers an operational rating system.

The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Over the past month, there's been a 168.54% rise in the Zacks Consensus EPS estimate. As of now, Oscar Health, Inc. holds a Zacks Rank of #3 (Hold).

With respect to valuation, Oscar Health, Inc. is currently being traded at a Forward P/E ratio of 65.9. This denotes a premium relative to the industry average Forward P/E of 9.21.

The Insurance - Multi line industry is part of the Finance sector. This industry currently has a Zacks Industry Rank of 143, which puts it in the bottom 42% of all 250+ industries.

The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

To follow OSCR in the coming trading sessions, be sure to utilize Zacks.com.

Zacks Names #1 Semiconductor Stock

This under-the-radar company specializes in semiconductor products that titans like NVIDIA don't build. It's uniquely positioned to take advantage of the next growth stage of this market. And it's just beginning to enter the spotlight, which is exactly where you want to be.

With strong earnings growth and an expanding customer base, it's positioned to feed the rampant demand for Artificial Intelligence, Machine Learning, and Internet of Things. Global semiconductor manufacturing is projected to explode from $452 billion in 2021 to $971 billion by 2028.

See This Stock Now for Free >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Oscar Health, Inc. (OSCR): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research